Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Eslicarbazepine Acetate, Atc N03af04 for the Period April 1St, 2023 - March 31St, 2025

Dpsq for Furniture (Generic, Robust and Office)

Conclusion of a Non-Exclusive Discount Agreement in Accordance with § 130A Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Colecalciferol (Atc Code: A11cc05).

Open House Contracts for Multiple Active Ingredients/Active Ingredient Combinations

Dynamic Acquisition System for the Choice of Companies and Subsequent Contracting of Bottled Mineral Water Supplies, Disposable Cups and Water Filter Sources as Well as All...

Conclusion of a Non-Exclusive Discount Agreement in Accordance with § 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Dornase Alfa (Atc Code: R05cb13).

Conclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Sevelamer Hydrochloride (Atc Code: V03ae02).

Drug Rebate Contracts with Option to Join - 0004-Rvbeitr.59-2023

Open House Procedure Contract According to § 31 Paragraph 1 and 1A Sgb V on the Supply of Bandages

Conclusion of Non-Exclusive Discount Agreements According to §§ 130A Abs. 8/130C Abs. 1 Sgb V for Drugs with the Active Ingredient Calcium Carbonate and Colecalciferol (A12ax01) as Part of an Open House Model.